메뉴 건너뛰기




Volumn 100, Issue 12, 2011, Pages 1059-1067

Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?

Author keywords

Brain natriuretic peptides; Chronic heart failure; Individually optimized heart failure therapy; Risk stratification; Serial measurements

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

EID: 84855994228     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0340-1     Document Type: Article
Times cited : (14)

References (48)
  • 5
    • 0027210870 scopus 로고
    • Survival after the onset of congestive heart failure in Framingham Heart Study subjects
    • Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88(1):107-115 (Pubitemid 23195439)
    • (1993) Circulation , vol.88 , Issue.1 , pp. 107-115
    • Ho, K.K.L.1    Anderson, K.M.2    Kannel, W.B.3    Grossman, W.4    Levy, D.5
  • 7
    • 44249118880 scopus 로고    scopus 로고
    • Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events
    • DOI 10.1007/s00392-007-0629-2
    • Simon T, Becker R, Voss F, Bikou O, Hauck M, Licka M, Katus HA, Bauer A (2008) Elevated b-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events. Clin Res Cardiol 97(5):306-309. doi:10.1007/ s00392-007-0629-2 (Pubitemid 351725056)
    • (2008) Clinical Research in Cardiology , vol.97 , Issue.5 , pp. 306-309
    • Simon, T.1    Becker, R.2    Voss, F.3    Bikou, O.4    Hauck, M.5    Licka, M.6    Katus, H.A.7    Bauer, A.8
  • 8
    • 1442265576 scopus 로고    scopus 로고
    • B-Type Natriuretic Peptide - A Biomarker for All Seasons?
    • DOI 10.1056/NEJMe038233
    • Mark DB, Felker GM (2004) B-type natriuretic peptide-A biomarker for all seasons? N Engl J Med 350(7):718-720. doi: 10.1056/NEJMe038233 (Pubitemid 38364631)
    • (2004) New England Journal of Medicine , vol.350 , Issue.7 , pp. 718-720
    • Mark, D.B.1    Felker, G.M.2
  • 10
    • 34848907988 scopus 로고    scopus 로고
    • Area under ROC curve, sensitivity, specificity of N-terminal probrain natriuretic peptide in predicting mortality in various subsets of patients with ischemic heart disease [4]
    • DOI 10.1007/s00392-007-0562-4
    • Ndrepepa G, Braun S, Kastrati A, Schomig A (2007) Area under roc curve, sensitivity, specificity of n-terminal probrain natriuretic peptide in predicting mortality in various subsets of patients with ischemic heart disease. Clin Res Cardiol 96(10): 763-765. doi:10.1007/s00392-007-0562-4 (Pubitemid 47493074)
    • (2007) Clinical Research in Cardiology , vol.96 , Issue.10 , pp. 763-765
    • Ndrepepa, G.1    Braun, S.2    Kastrati, A.3    Schomig, A.4
  • 11
    • 33748072422 scopus 로고    scopus 로고
    • Raised B-type natriuretic peptide predicts implantable cardioverter- defibrillator therapy in patients with ischaemic cardiomyopathy [4]
    • DOI 10.1136/hrt.2005.076117
    • Klingenberg R, Zugck C, Becker R, Schellberg D, Heinze G, Kell R, Remppis A, Schoels W, Katus HA, Dengler TJ (2006) Raised b-type natriuretic peptide predicts implantable cardioverterdefibrillator therapy in patients with ischaemic cardiomyopathy. Heart 92(9):1323-1324. doi:10.1136/hrt.2005.076117 (Pubitemid 44298896)
    • (2006) Heart , vol.92 , Issue.9 , pp. 1323-1324
    • Klingenberg, R.1    Zugck, C.2    Becker, R.3    Schellberg, D.4    Heinze, G.5    Kell, R.6    Remppis, A.7    Schoels, W.8    Katus, H.A.9    Dengler, T.J.10
  • 15
    • 0034176934 scopus 로고    scopus 로고
    • Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
    • Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM (2000) Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355(9210):1126-1130 (Pubitemid 30172933)
    • (2000) Lancet , vol.355 , Issue.9210 , pp. 1126-1130
    • Troughton, R.W.1    Frampton, C.M.2    Yandle, T.G.3    Espiner, E.A.4    Nicholls, M.G.5    Richards, A.M.6
  • 16
    • 1342333833 scopus 로고    scopus 로고
    • NT-proBNP and BNP: Biomarkers for heart failure management
    • DOI 10.1016/j.ejheart.2004.01.008
    • Bettencourt P (2004) NT-proBNP and BNP: Biomarkers for heart failure management. Eur J Heart Fail 6(3):359-363. doi:10.1016/ j.ejheart.2004.01.008 (Pubitemid 38253058)
    • (2004) European Journal of Heart Failure , vol.6 , Issue.3 , pp. 359-363
    • Bettencourt, P.1
  • 19
    • 72549097700 scopus 로고    scopus 로고
    • N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: Results from the BATTLESCARRED (NT-proBNP-assisted treatment to lessen serial cardiac readmissions and death) trial
    • doi:10.1016/j.jacc.2009.02.095
    • Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG, Hamid AK, Nicholls MG, Richards AM (2009) N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: Results from the BATTLESCARRED (NT-proBNP-assisted treatment to lessen serial cardiac readmissions and death) trial. J Am Coll Cardiol 55(1): 53-60. doi:10.1016/j.jacc.2009.02.095
    • (2009) J Am Coll Cardiol , vol.55 , Issue.1 , pp. 53-60
    • Lainchbury, J.G.1    Troughton, R.W.2    Strangman, K.M.3    Frampton, C.M.4    Pilbrow, A.5    Yandle, T.G.6    Hamid, A.K.7    Nicholls, M.G.8    Richards, A.M.9
  • 20
    • 77955227797 scopus 로고    scopus 로고
    • Inflammation increases Nt-proBNP and the NT-proBNP/BNP ratio
    • doi: 10.1007/s00392-010-0140-z
    • Jensen J, Ma LP, Fu ML, Svaninger D, Lundberg PA, Hammarsten O (2010) Inflammation increases Nt-proBNP and the NT-proBNP/BNP ratio. Clin Res Cardiol 99(7):445-452. doi: 10.1007/s00392-010-0140-z
    • (2010) Clin Res Cardiol , vol.99 , Issue.7 , pp. 445-452
    • Jensen, J.1    Ma, L.P.2    Fu, M.L.3    Svaninger, D.4    Lundberg, P.A.5    Hammarsten, O.6
  • 21
    • 63449100423 scopus 로고    scopus 로고
    • Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation
    • doi:10.1007/s00392-009-0744-3
    • Hwang HJ, Son JW, Nam BH, Joung B, Lee B, Kim JB, Lee MH, Jang Y, Chung N, Shim WH, Cho SY, Kim SS (2009) Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation. Clin Res Cardiol 98(4):213-218. doi:10.1007/s00392- 009-0744-3
    • (2009) Clin Res Cardiol , vol.98 , Issue.4 , pp. 213-218
    • Hwang, H.J.1    Son, J.W.2    Nam, B.H.3    Joung, B.4    Lee, B.5    Kim, J.B.6    Lee, M.H.7    Jang, Y.8    Chung, N.9    Shim, W.H.10    Cho, S.Y.11    Kim, S.S.12
  • 23
    • 50949104678 scopus 로고    scopus 로고
    • Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)
    • doi: 10.1016/j.jacc.2008.04.069
    • Masson S, Latini R, Anand IS, Barlera S, Angelici L, Vago T, Tognoni G, Cohn JN (2008) Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial). J Am Coll Cardiol 52(12):997-1003. doi: 10.1016/j.jacc.2008.04.069
    • (2008) J Am Coll Cardiol , vol.52 , Issue.12 , pp. 997-1003
    • Masson, S.1    Latini, R.2    Anand, I.S.3    Barlera, S.4    Angelici, L.5    Vago, T.6    Tognoni, G.7    Cohn, J.N.8
  • 24
    • 63849177462 scopus 로고    scopus 로고
    • 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults a report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation
    • doi:10.1016/j.jacc.2008.11.013
    • Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults a report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation. J Am Coll Cardiol 53(15):e1-e90. doi:10.1016/j.jacc.2008.11.013
    • (2009) J Am Coll Cardiol , vol.53 , Issue.15
    • Hunt, S.A.1    Abraham, W.T.2    Chin, M.H.3    Feldman, A.M.4    Francis, G.S.5    Ganiats, T.G.6    Jessup, M.7    Konstam, M.A.8    Mancini, D.M.9    Michl, K.10    Oates, J.A.11    Rahko, P.S.12    Silver, M.A.13    Stevenson, L.W.14    Yancy, C.W.15
  • 28
    • 65949114655 scopus 로고    scopus 로고
    • Variability of n-terminal probrain natriuretic peptide in stable chronic heart failure and its relation to changes in clinical variables
    • doi:10.1373/clinchem.2008.112052
    • Frankenstein L, Remppis A, Frankenstein J, Hess G, Zdunek D, Slottje K, Katus HA, Zugck C (2009) Variability of n-terminal probrain natriuretic peptide in stable chronic heart failure and its relation to changes in clinical variables. Clin Chem 55(5): 923-929. doi:10.1373/clinchem.2008.112052
    • (2009) Clin Chem , vol.55 , Issue.5 , pp. 923-929
    • Frankenstein, L.1    Remppis, A.2    Frankenstein, J.3    Hess, G.4    Zdunek, D.5    Slottje, K.6    Katus, H.A.7    Zugck, C.8
  • 29
    • 17744373270 scopus 로고    scopus 로고
    • N-Terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction: A study in patients presenting with suspected cardiac disorders
    • DOI 10.1007/s00392-005-0205-6
    • Hess G, Moecks J, Zdunek D (2005) N-terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction. A study in patients presenting with suspected cardiac disorders. Z Kardiol 94(4):247-254. doi:10.1007/s00392-005-0205-6 (Pubitemid 40576519)
    • (2005) Zeitschrift fur Kardiologie , vol.94 , Issue.4 , pp. 247-254
    • Hess, G.1    Moecks, J.2    Zdunek, D.3
  • 31
    • 34247866537 scopus 로고    scopus 로고
    • Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure
    • DOI 10.1016/j.jacc.2007.02.037, PII S0735109707007681
    • Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M (2007) Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 49(19):1943-1950. doi:10.1016/j.jacc.2007.02.037 (Pubitemid 46694287)
    • (2007) Journal of the American College of Cardiology , vol.49 , Issue.19 , pp. 1943-1950
    • Fonarow, G.C.1    Peacock, W.F.2    Phillips, C.O.3    Givertz, M.M.4    Lopatin, M.5
  • 32
    • 5644268954 scopus 로고    scopus 로고
    • N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients
    • DOI 10.1161/01.CIR.0000144310.04433.BE
    • Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A (2004) N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110(15):2168-2174. doi:10.1161/01.CIR.0000144310. 04433.BE (Pubitemid 39372496)
    • (2004) Circulation , vol.110 , Issue.15 , pp. 2168-2174
    • Bettencourt, P.1    Azevedo, A.2    Pimenta, J.3    Frioes, F.4    Ferreira, S.5    Ferreira, A.6
  • 33
    • 0037432301 scopus 로고    scopus 로고
    • Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
    • DOI 10.1161/01.CIR.0000054164.99881.00
    • Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan heart failure trial (Val-heft). Circulation 107(9):1278-1283 (Pubitemid 36314411)
    • (2003) Circulation , vol.107 , Issue.9 , pp. 1278-1283
    • Anand, I.S.1    Fisher, L.D.2    Chiang, Y.-T.3    Latini, R.4    Masson, S.5    Maggioni, A.P.6    Glazer, R.D.7    Tognoni, G.8    Cohn, J.N.9
  • 34
    • 34547756324 scopus 로고    scopus 로고
    • Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a β-blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial
    • DOI 10.1016/j.ejheart.2007.07.010, PII S1388984207002711
    • Olsson LG, Swedberg K, Cleland JG, Spark PA, Komajda M, Metra M, Torp-Pedersen C, Remme WJ, Scherhag A, Poole- Wilson P (2007) Prognostic importance of plasma nt-pro bnp in chronic heart failure in patients treated with a beta-blocker: Results from the carvedilol or metoprolol european trial (COMET) trial. Eur J Heart Fail 9(8):795-801. doi:10.1016/j.ejheart.2007. 07.010 (Pubitemid 47225165)
    • (2007) European Journal of Heart Failure , vol.9 , Issue.8 , pp. 795-801
    • Olsson, L.G.1    Swedberg, K.2    Cleland, J.G.F.3    Spark, P.A.4    Komajda, M.5    Metra, M.6    Torp-Pedersen, C.7    Remme, W.J.8    Scherhag, A.9    Poole-Wilson, P.10
  • 35
    • 66249125916 scopus 로고    scopus 로고
    • The prognostic value of repeated measurement of N-terminal pro- B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction
    • doi:10.1093/eurjhf/hfp003
    • Kubanek M, Goode KM, Lanska V, Clark AL, Cleland JG (2009) The prognostic value of repeated measurement of N-terminal pro- B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 11(4):367-377. doi:10.1093/eurjhf/hfp003
    • (2009) Eur J Heart Fail , vol.11 , Issue.4 , pp. 367-377
    • Kubanek, M.1    Goode, K.M.2    Lanska, V.3    Clark, A.L.4    Cleland, J.G.5
  • 36
    • 0347539775 scopus 로고    scopus 로고
    • Plasma b-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure
    • DOI 10.1161/01.CIR.0000106903.98196.B6
    • Tang WH, Girod JP, Lee MJ, Starling RC, Young JB, Van Lente F, Francis GS (2003) Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 108(24):2964-2966. doi:10.1161/ 01.CIR.0000106903.98196.B6 (Pubitemid 37553562)
    • (2003) Circulation , vol.108 , Issue.24 , pp. 2964-2966
    • Tang, W.H.W.1    Girod, J.P.2    Lee, M.J.3    Starling, R.C.4    Young, J.B.5    Van Lente, F.6    Francis, G.S.7
  • 37
    • 77955456594 scopus 로고    scopus 로고
    • Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care
    • doi:10.1093/eurheartj/ehq163
    • Hildebrandt P, Collinson PO, Doughty RN, Fuat A, Gaze DC, Gustafsson F, Januzzi J, Rosenberg J, Senior R, Richards M (2010) Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. Eur Heart J 31(15):1881-1889. doi:10.1093/eurheartj/ehq163
    • (2010) Eur Heart J , vol.31 , Issue.15 , pp. 1881-1889
    • Hildebrandt, P.1    Collinson, P.O.2    Doughty, R.N.3    Fuat, A.4    Gaze, D.C.5    Gustafsson, F.6    Januzzi, J.7    Rosenberg, J.8    Senior, R.9    Richards, M.10
  • 38
    • 0037531814 scopus 로고    scopus 로고
    • The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population
    • Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, Pedersen F (2003) The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 89(7):745-751 (Pubitemid 36760633)
    • (2003) Heart , vol.89 , Issue.7 , pp. 745-751
    • Raymond, I.1    Groenning, B.A.2    Hildebrandt, P.R.3    Nilsson, J.C.4    Baumann, M.5    Trawinski, J.6    Pedersen, F.7
  • 39
    • 34547629797 scopus 로고    scopus 로고
    • Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality
    • DOI 10.1373/clinchem.2006.084533
    • deFilippi CR, Seliger SL, Maynard S, Christenson RH (2007) Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin Chem 53(8):1511-1519. doi:10.1373/clinchem.2006.084533 (Pubitemid 47206349)
    • (2007) Clinical Chemistry , vol.53 , Issue.8 , pp. 1511-1519
    • DeFilippi, C.R.1    Seliger, S.L.2    Maynard, S.3    Christenson, R.H.4
  • 40
    • 7044284668 scopus 로고    scopus 로고
    • High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure
    • DOI 10.1373/clinchem.2004.038752
    • Bruins S, Fokkema MR, Romer JW, Dejongste MJ, van der Dijs FP, van den Ouweland JM, Muskiet FA (2004) High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 50(11):2052-2058. doi:10.1373/clinchem. 2004.038752 (Pubitemid 39425842)
    • (2004) Clinical Chemistry , vol.50 , Issue.11 , pp. 2052-2058
    • Bruins, S.1    Fokkema, M.R.2    Romer, J.W.P.3    Dejongste, M.J.L.4    Van Der Dijs, F.P.L.5    Van Den Ouweland, J.M.W.6    Muskiet, F.A.J.7
  • 41
    • 0041508543 scopus 로고    scopus 로고
    • Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure
    • DOI 10.1016/S0002-9149(03)00741-0
    • Wu AH, Smith A, Wieczorek S, Mather JF, Duncan B, White CM, McGill C, Katten D, Heller G (2003) Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92(5):628-631 (Pubitemid 37013426)
    • (2003) American Journal of Cardiology , vol.92 , Issue.5 , pp. 628-631
    • Wu, A.H.B.1    Smith, A.2    Wieczorek, S.3    Mather, J.F.4    Duncan, B.5    White, C.M.6    McGill, C.7    Katten, D.8    Heller, G.9
  • 42
    • 0032736511 scopus 로고    scopus 로고
    • Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy
    • Murdoch DR, McDonagh TA, Byrne J, Blue L, Farmer R, Morton JJ, Dargie HJ (1999) Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 138(6 Pt 1):1126-1132
    • (1999) Am Heart J , vol.138 , Issue.6 PART 1 , pp. 1126-1132
    • Murdoch, D.R.1    McDonagh, T.A.2    Byrne, J.3    Blue, L.4    Farmer, R.5    Morton, J.J.6    Dargie, H.J.7
  • 44
    • 1242295182 scopus 로고    scopus 로고
    • Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure
    • DOI 10.1016/j.jacc.2003.09.044
    • Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC (2004) Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43(4): 635-641. doi:10.1016/j.jacc.2003.09.044 (Pubitemid 38229537)
    • (2004) Journal of the American College of Cardiology , vol.43 , Issue.4 , pp. 635-641
    • Logeart, D.1    Thabut, G.2    Jourdain, P.3    Chavelas, C.4    Beyne, P.5    Beauvais, F.6    Bouvier, E.7    Solal, A.C.8
  • 45
    • 33947139106 scopus 로고    scopus 로고
    • Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization
    • DOI 10.1016/j.ijcard.2006.06.004, PII S0167527306005031
    • Bettencourt P, Azevedo A, Fonseca L, Araujo JP, Ferreira S, Almeida R, Rocha-Goncalves F, Ferreira A (2007) Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization. Int J Cardiol 117(1):75-79. doi:10.1016/j.ijcard.2006. 06.004 (Pubitemid 46399972)
    • (2007) International Journal of Cardiology , vol.117 , Issue.1 , pp. 75-79
    • Bettencourt, P.1    Azevedo, A.2    Fonseca, L.3    Araujo, J.P.4    Ferreira, S.5    Almeida, R.6    Rocha-Goncalves, F.7    Ferreira, A.8
  • 46
    • 14544270490 scopus 로고    scopus 로고
    • Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure
    • DOI 10.1373/clinchem.2004.041582
    • Miller WL, Hartman KA, Burritt MF, Borgeson DD, Burnett JC Jr, Jaffe AS (2005) Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure. Clin Chem 51(3):569-577. doi:10.1373/ clinchem.2004.041582 (Pubitemid 40300233)
    • (2005) Clinical Chemistry , vol.51 , Issue.3 , pp. 569-577
    • Miller, W.L.1    Hartman, K.A.2    Burritt, M.F.3    Borgeson, D.D.4    Burnett Jr., J.C.5    Jaffe, A.S.6
  • 47
    • 33847021875 scopus 로고    scopus 로고
    • Longterm clinical variation of NT-proBNP in stable chronic heart failure patients
    • doi:10.1093/ eurheartj/ehl449
    • Schou M, Gustafsson F, Kjaer A, Hildebrandt PR (2007) Longterm clinical variation of NT-proBNP in stable chronic heart failure patients. Eur Heart J 28(2):177-182. doi:10.1093/ eurheartj/ehl449
    • (2007) Eur Heart J , vol.28 , Issue.2 , pp. 177-182
    • Schou, M.1    Gustafsson, F.2    Kjaer, A.3    Hildebrandt, P.R.4
  • 48
    • 0034332845 scopus 로고    scopus 로고
    • High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure
    • Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Kinoshita M (2000) High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 36(5):1587-1593
    • (2000) J Am Coll Cardiol , vol.36 , Issue.5 , pp. 1587-1593
    • Maeda, K.1    Tsutamoto, T.2    Wada, A.3    Mabuchi, N.4    Hayashi, M.5    Tsutsui, T.6    Ohnishi, M.7    Sawaki, M.8    Fujii, M.9    Matsumoto, T.10    Kinoshita, M.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.